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Summary 
We analyzed the phenotype and VB-T cell receptor (TCR) repertoire, together with interleukin 
7 receptor (IL-7R) expression in unfractionated thymocytes stimulated in vitro with IL-7. This 
culture  system  results  in  a  specific  proliferation  of mature  thymocytes belonging  to  the 
CD3+CD4 -,  CD4+8 -,  and  CD4-8 +  subsets.  IL-7  induced  a  preferential  expansion  of 
V38.2 +  CD4- 8-  and V38.2 +  CD4- 8-  thymocytes. This phenomenon is not observed in 32- 
microglobulin-deficient mice,  showing that  a  fraction of CD4+8 -  thymocytes, enriched in 
V38.2 §  cells,  is  selected by class  I  molecules in  normal mice,  as  are a  large proportion  of 
CD4-8-o~BTCR + thymocytes. Our findings also establish  that IL-7 plays a major role in the 
expansion of rare thymocyte subsets,  which could exert important functions in inflammatory 
and immune responses. 
T  lymphocyte maturation involves coordinate rearrange- 
ment of TCR genes in committed precursor cells which 
will be selected to differentiate into mature T  cells. Those 
steps are closely dependent on the thymic microenvironment 
and implicate cell-to-cell interactions or cytokines (1). Con- 
cerning the latter,  it  is now generally acknowledged that 
they induce a preferential expansion of particular thymocyte 
subsets (1). 
Recent data point to the involvement oflL-7 in intrathymic 
development in adult mice. Its implication in thymopoiesis 
is suggested both by its predominant mRNA expression in 
the thymus and the studies on IL-7 transgenic mice (2,  3, 
4).  This notion is also  supported by in vitro experiments 
showing that IL-7 exerts biological effects on distinct thymic 
subsets.  The earliest IL-7-responsive cells are the immature 
CD44 §  CD25 +,  CD3-4- 8-  thymocytes, whose viability 
is maintained, apparently without proliferation or differen- 
tiation (5, 6). Furthermore, IL-7 exerts a proliferative effect 
on mature  CD3 +  thymocytes,  namely  CD4-8-TCR +, 
CD4 +  8-,  and CD4- 8 + thymocyte subsets  (6-8). 
A  particular  feature of CD4-8-TCRc~3 +  thymocytes, 
relative to mature CD4+8-  and CD4-8 + thymocytes and 
peripheral T lymphocytes, consists of overexpression of the 
VBS.2 gene family (9,  10). It has recently been shown that 
the  majority  of  these  supernumerary  CD4-8-V38.2 + 
thymocytes are positively selected by class I molecules, since 
they are absent from 32-microglobulin-deficient mice (11). 
In keeping with these data, a particular subset of CD4 § 8- 
thymocytes, called Thy0, also presents overusage of the V38.2 
gene family, but little is known about the way they are selected 
(12).  No such subset has been described among CD4-8 + 
thymocytes. 
We have recently found that stimulation of total thymo- 
cytes by IL-7 results in preferential proliferation of CD4-8- 
TCRc~3+  and CD4-8-TCRy~ + cells and, to a lesser ex- 
tent,  in CD4+8 -  and CD4-8 + cell expansion  (13,  13a). 
The aim of the present study was to analyze the IL-7R ex- 
pression in relation to the V3TCR repertoire in IL-7-cul- 
tured thymocytes. We demonstrate herein that IL-7 prefer- 
entially  expands  CD4-8-V38.2 +  and  CD4+8-V38.2 + 
thymocytes in normal but not in 32-microglobulin-deficient 
mice, indicating that IL-7 plays a major role in the expansion 
of rare thymocyte subsets. 
Materials and Methods 
Mice.  4- to 6-wk-old male C3H/HeJ low endotoxin-responder 
mice were purchased from CSEAL (Orl6ans, France). 32-micro- 
globulin-deficient mutant mice of the 129 strain (-/-)  (14), here- 
after referred to as 32m-, and wild-type littermates, referred to 
as 32m +, were bred in our own facilities by backcross generation 
from heterozygous 32m §  mice. First, 32m §  breeders and 
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Class II*) were obtained from CSEAL (Orleans, France). 
In Vitro Culture of Thymk Cells.  Single-cell thymocyte suspen- 
sions  were  prepared  in  RPMI  1640 medium  (GIBCO  BRL, 
Gaithersburg,  MD) containing  10% heat-inactivated FCS (Flow 
Laboratories, Irvine, Scotland), 10 mM Hepes buffer, 2 mM t-glu- 
tamine, 100 IU/ml penicillin, 100/~g/ml streptomycin (all from 
GIBCO BILL), and 0.05 mM 2-ME (culture medium).  Cultures 
were carried out at 37~  in 24-weU plates (Costar, Cambridge, 
MA)  using  15  x  106 unseparated  thymocytes/well  in  a  total 
volume of 0.5 ml. In some experiments, 10  x  106 of both/~2m + 
and/~2m-  thymocytes were mixed in a total volume of 0.5 ml, 
and then incubated for 4 or 9 d with 100 U/ml human recom- 
binant IL-7 (hrIL-71, specific activity of 8.8  x  106 U/mg) kindly 
provided by Sterling Winthrop,  Inc. (CoUegeville,  PA). At the end 
of culture, thymocytes were harvested and dead ceils were removed 
by density gradient centrifugation (Lympholyte M; Cedarlane, On- 
tario, Canada). 
Depletion ofCD8 + Thymocytes.  To analyze the V/~-TCR reper- 
toire of freshly isolated CD4-8-  and CD4+8-  thymocytes, to- 
gether with Ib7R expression, we depleted thymocyte suspensions 
of CD8 § calls. Briefly, total  thymocytes  were  incubated  with 
purified anti-CD8 (done 3155) followed by low-tox-M rabbit com- 
plement (Cedarlane), washed extensively, and then incubated with 
another purified anti-CD8  (done 53-6.7), followed by depletion 
with anti-rat  Ig coated magnetic beads (Dynal, Oslo, Norway). 
Purification was assessed by staining the remaining  cells with a 
third anti-CD8 (clone YTS-169.4). CD8 + contaminants were rou- 
tinely <2%. 
Immunofluorescence Labeling and Flow Cytometry.  For surface an- 
tigen detection, cells were resuspended in PBS containing 5% FCS 
and 0.02% sodium azide and incubated for 30 min with an appro- 
priate dilution  of antibody. The following antibodies were used 
for double or triple labeling: anti-cxBTCR (done H57-97), anti- 
V~6 (done 44.22.1), anti-V~8.2 (done F23.2), anti-V/~14 (clone 
14-2), antiqr#TCIL (clone GL3), anti-HSA (clone  Jlld), anti-CD44 
(clone 1M781), anti-CD25  (done PC61), anti-Ia (done M5-114), 
anti-H-2K b (clone 34-1-2S), anti-CD4  (clone GK1.5),  and anti- 
CD8 (clone 53-6.7), coupled to biotin, FITC or PE. For triple 
labeling, biotinylated antibodies were revealed  using Tricolor-strep- 
tavidin (Caltag Labs, San Francisco, CA). 
Flow cytometry was performed using a FACScan apparatus (a 
registered trademark of Becton Dickinson,  Mountain  View, CA) 
equipped with a 488-nm argon  laser. In double-labeling experi- 
ments, cell suspensions were analyzed after propidium  iodide ex- 
clusion of dead cells. At least 104 lymphoid cells were acquired in 
each run and the results were analyzed using Lysys II software. 
II_,TR Detection.  We used biotinylated  routine  II.-7 to detect 
IL-7R by means of flow cytometry (16). Briefly, 106 cells were in- 
cubated for 60 rain on ice with 10 ill of a 10/zg/ml biotinylated 
murine IL-7 solution (British Biotechnology, Oxon, UK). Unbound 
cytokine was removed by washing the cells twice followed by an- 
other incubation for 30 min with 10/xl of PE-streptavidin second- 
step reagent (British Bio-technology) or Tricolor-streptavidin. The 
specificity of biotinylated murine II.,7 labeling was assessed by its 
reversal in the presence of a 80-fold molar excess  of unlabeled human 
11_,7 (data not shown). 
Analysis of DNA-synthesizing cells.  Total  thymocytes were in- 
cubated with IL-7 for 4 d and with 100/zg/ml bromodeoxyuridine 
1  Abbreviations used in this paper: BrdUrd, bromodeoxyuridine; hrlL-7, 
human recombinant IL-7. 
(BrdUrd) for the last 15 h of culture.  BrdUrd incorporation  by 
DNA synthesizing cells was analyzed by flow cytometry with a 
three color labeling technique (17). Briefly, cultured cells were sur- 
face stained with appropriate combinations of anti-CD4, anti-CD8, 
anti-ot/~TCR, anti-VB6, anti-V~8.2, anti-V~14, or anti-'fltTCR, 
coupled to either biotin or PE. Biotinylated antibodies were re- 
vealed with Tricolor-streptavidin.  Cells were then fixed for 48 h 
at 4~  in 1% paraformaldehyde containing 0.01% Tween 20 and 
incubated with pancreatic deoxyribonudease  I (Pharmacia, Upp- 
sala, Sweden) for 1 h at 37~  BrdUrd incorporated  into DNA 
was  detected  with  the  76/7  antibody  and  FITC-conjugated 
anti-mouse IgG1. The negative control consisted of cultured cells 
labeled by the same procedure but without BrdUrd incubation. 
Results 
The CD4 - CD8-  Thymocyte Subset Is the Predominant Cell 
Population Recovered after 1L-7 Stimulation.  We have previ- 
ously described that  IL-7 induces a strong proliferative re- 
sponse of unseparated thymocytes, that peaks after 3-4 d of 
culture (13). As illustrated in Table 1, a 4-d incubation with 
II.-7  results  in  a  preferential  expansion  of  CD4-CD8- 
thymocytes,  the  second major  subset being CD4+CD8 -. 
Some  CD4-CD8 +  thymocytes  were  also  present,  while 
nearly all  CD4+CD8 + cells  had disappeared. 
Phenotypic Analysis of CD4- CD8-  and CD4 +  CD8-  IL- 
7-stimulated  Thymocytes.  We  analyzed  the  expression  of 
CD44,  CD25,  HSA,  otflTCR,  3diTCtL,  and  Ib7R  in 
CD4-8-  and CD4 +  8-  thymocyte after 4-d stimulation of 
total thymocytes with IL-7 relative to freshly isolated thymo- 
cytes. Table 2 shows that all CD4-8-  thymocytes recovered 
after 4  d  of IL-7 stimulation  expressed either  a~TC1L  or 
q/~TCtL.  The vast majority were mature  HSA-  and  acti- 
vated CD44 + T  cells bearing IL-7R. They also homogene- 
ously expressed intermediate CD25 levels, i.e., at a lower in- 
tensity  than  fresh  CD4-8-  thymocytes.  All  CD4+8 - 
thymocytes were mature otflTCtL T ceils, as defined by low 
HSA expression. About one third were IL-7R +, while only 
10-20%  were CD25 + or CD44 §  In both  CD4-8-  and 
CD4+8 -  thymocyte  populations,  II~7R  expression  cor- 
responded to a larger  cell size  (data not  shown). 
IL-7 Promotes the Preferential Expansion of Vf18.2 § Thymo- 
cytes from Normal Mice.  We analyzed the actual cell recov- 
eries  of  CD4-8-  and  CD4 § 8-  thymocytes  expressing 
different V~/s after 4 d of Ib7 stimulation and found a preferen- 
tial  recovery  of V/38.2 §  cells  (Table  3).  More  precisely, 
CD4- 8- VB8.2 §  thymocytes expanded  approximately  10- 
fold when CD4-8-  thymocytes expressing other VBs ex- 
panded  approximately  three  fold.  Concerning  CD4+8 - 
thymocytes, we did not observe enhanced recovery of any 
particular  subset, but the recovery of CD4+CD8-V/38.2 § 
thymocytes was only slightly diminished whereas those of 
CD4§  -  thymocytes  expressing  other  VBs  decreased  by 
twofold. This result may reflect the heterogeneity of the sen- 
sitivity of CD4 +  8-  thymocytes to IL-7 rather than a selec- 
tive survival, as only a fraction of them expressed IL-7K (Table 
2) and as a notable proportion of CD4 § 8- thymocytes died 
during the first days of culture (data not shown). We inves- 
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*Viable cell recovery  x  10 .6 
CD4-CD8-  CD4 +CD8 +  CD4 +CD8-  CD4-CD8 + 
Day 0  *2.2  _+  1.1  83.1  •  1.2  9.7  •  1.0  4.6  _+  1.0 
Day 4  +  IL-7  8.5  _+  3.5  0.7  •  0.8  4.6  •  0.9  2.6  •  0.8 
* Day 0 or day 4 IL-7-stimulated thymic calls from C3H/HeJ mice were stained with fluorcscently  labded antibodies  specific for CD4 and CD8 
and analyzed by two-color flow cytometry. Dead cells and debris were eliminated  by propidium iodide exclusion.  Cultures were set up with 15  x 
10  ~ unseparated  thymic cells in 0.5 ml of culture medium containing 100 U/ml hrlL-7. 
* Results are expressed as mean  •  SD of five separate experiments.  They represent  viable cell recovery calculated from 10  s cells at the beginning 
of culture. 
Table 2.  Phenotype  of CD4-8-  and CD4+8-  Thymocytes before and after 4 d of lL-7 Stimulation 
Percentage  of positive cells in gated populations 
CD4-8-  CD4 +8-  CD4-8-  CD4 +8- 
￿9 day 0  day 4  +  IL-7 
o~/3-TCR +  *32  99  76  99 
~/6-TCR §  20  0  23  0 
CD25 +  34  6  62  10 
CD44 +  25  8  85  13 
HSA ￿9  80  56  10  18 
IL-7K  +  44  25  95  32 
* Freshly isolated or cultured thymocytes  exposed for 4 d to II.v7 were stained with anti-CD4-PE, anti-CD8-FITC, and the appropriate  biotinylated 
antibody or biotinylated  mrIL,7,  plus Tricolor-streptavidin,  and then analyzed by three-color flow cytometry.  Cultures were set up with 15  x  106 
unfractionated  thymic cells in 0.5 ml of culture medium containing 100 U/ml hrIL,7. 
* Results are expressed as the percentage of positive cells compared to staining with Tricolor--strepta~din alone, in one of three independent experiments. 
Table  3.  Recovery of CD4-8-  and CD4*8 -  Thymocytes Expressing Different V~s after 4 d of Culture with IL-7 
"Viable cell recovery  x  10 -s 
CD4-8-  CD4+8 -  CD4-8-  CD4+8 - 
&y O  day4  +  IL-7 
V~6 +  *0.7  •  0.3  10.9  +  0.8  2.3  +  0.5  4.5  +_  0.5 
V/~8.2 §  2.7  •  0.8  12.7  •  1  28.4  •  1.1  10.4  •  1.2 
V/314 +  0.04  +_  0.2  5.9  •  0.8  0.13  +  0.2  2.4  •  0.3 
* Freshly isolated or cultured thymocytes exposed for 4 d to IL-7 were stained with anti-CD4-PE, anti-CD8-FITC, and the appropriate  biotinyhted 
anti-V/~ antibody plus Tricolor-streptavidin. Cultures were set up with 15  x  106 unfractionated  thymic cells in 0.5 ml of culture medium contain- 
ing t00 U/mi hrIL-7. 
* Results are expressed as mean  •  SD of three separate experiments.  They represent  viable cell recovery in each subpopulation  calculated from 10  s 
cells at the beginning of culture. 
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Repertoire in IL-7-stimulated  Thymocytes 
"Percentage of BrdUrd-positive cells 
in gated populations 
CD4 - 8 -  CD4 §  8 - 
Gated in 
Total  69  +  3  12  +  2 
c~TCR +  70  +  2  12  +  2 
31#TCR +  68  ND 
V36 +  65  _+  1  12  _+  2 
V~8.2 +  73  +  2  22  _+  3 
V~14 §  65  +  6  10  +  1 
" Cultures were performed with 15  x  10  ~ unseparated thymic cells from 
C3H/HeJ mice, incubated for 4 d in 0.5 ml of culture medium contain- 
ing 100 U/ml rhlL-7.  BrdUrd (100/~M) was incorporated during the 
last 15 h of culture.  Cells were  stained with anti-CD4-PE  plus anti- 
CDS-PE, the appropriate  biotinyhted antibody, and Tricolor-streptavidin. 
BrdUrd-incorporatiug  cells were  revealed using  a standard  technique 
described  in  Materials  and  Methods.  The  percentage  of  BrdUrd- 
incorporating cells was determined by comparison with the staining of 
cells not incubated with BrdUrd.  Results are expressed as mean percen- 
tages •  SD from three separate experiments, except for 7~TCR § (two 
experiments). 
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50 
30- 
20- 
I0 
v~  v~14  vCs.z  vex4 v~  v~s~ 
t 
[]  IL-TR.  ] 
[]  IL-7R+ 
A 
IJ.,-TR§ 
B 
tigated DNA-synthesizing cells together with TCR  reper- 
toire  in  our  system by  incubating  total  thymocytes with 
BrdUrd during the last 15 h of a 4-d Ib7 stimulation (Table 
4).  According to the expansion of CD4-8-  cells, the per- 
centage of BrdUrd-incorporating Vf18.2 +  cells was higher 
in CD4-8-  than in CD4 +  8- cells. The numbers of cycling 
cells of the different phenotypes calculated on the basis of 
the data of Tables 3  and 4  indicate that VflS.2 §  cells rep- 
resent  the  great majority of cycling cells in both  subsets. 
These results dearly indicate a preferential proliferative re- 
sponse, rather than a better survival, of VflS.2 + cells of both 
CD4-8-  or CD4+8 -  phenotypes, in the presence of Ib7. 
Figure  1.  V~-TCR repertoire of CD4-8-a/3TCR + and CD4+8 - 
thymocytes according to IL-7R expression  before and after 4-d IL-7  stimu- 
lation. The VB-TCR repertoire was analyzed by three-color flow cytom- 
etry in CD8+-dephted thymocytes before (Day 0) and after exposure to 
IL7 (Day 4 + 1/.,7). In CD4-8-otBTCR § (,4) and CD4~8 - (/3) thymo- 
cytes. The V/3-TCR repertoire is represented as the percentage of positive 
cells among IL-7R- (hatched) and IL-TR  + (solid)  populations. Results are 
mean percentages  of two separate  experiments for Day 0 and mean percen- 
tages  •  SD of three separate experiments for Day 4. 
Repertoire of IL,7R-  Venus IL,7R + Cells among  CD4- 8- 
ozBTCR § and CD4+8 -  T~mocytes.  As VB8.2 + cells pro- 
liferated preferentially in our IL-7-dependent culture system, 
we analyzed the VBTCR  repertoire of CD4-8-oa3TCR  + 
Table  5.  IL-7R Expression According to  the V~-TCR  Repertoire in CD4-8-  and CD4+8 -  Thyraocytes before and after 4 d 
of IL-7 Stimulation 
"Percentage of IL-7R  §  in CD4-8-  Percentage of IL-7R § in CD4~8 - 
Day0  Day4  +  IL-7  Day0  Day4  +  IL-7 
aBTCR +  *93  93  29  32 
V~6 §  92  90  32  28 
Vf18.2 §  98  96  31  49 
V~14 +  98  95  32  32 
" Day 0 CD8 + depleted or 4-d IL-7-stimulated thymic cells from C3H/HeJ mice were stained with anti-CD4PE, the appropriate antibody coupled 
to FITC and biotinylated mrlL-7,  revealed by Tricolor-streptavidin,  then analyzed by three-color flow cytometry. Cultures were performed with 
15  x  106 unseparated thymic cells incubated for 4 d in 0.5 ml of culture medium containing  100 U/ml rhlL-7. 
* Results are expressed as the percentage of positive cells for IL-7R compared to control,  in one representative experiment out of three. 
656  Interleukin 7 Stimulates Class I-selected CD4-8-  and CD4+8 -  Thymocytes Table  6.  Recovery of CD4-,  CD8-,  and 0,8 TCR +-defined Thymocyte Subsets after a 4-d Exposure to 11,.7 
in B2m + and B2m-  Mice 
*Viable cell recovery  x  10 -6 
CD4 - CD8-  CD4 +  8 +  CD4 +  8 -  CD4 - 8 +  CD4 -  8 -  o~3TCR + 
Day 0 32m +  )3.3  84.6  10.3  1.8  1.1 
Day 0 32m-  5.3  87.6  6.4  0.7  1.0 
Day 4  +  IL-7 32m +  13.6  1.6  7.6  2.2  8.1 
Day 4  +  IL-7 32m-  9.4  1.3  11.5  0.7  5.2 
" Day 0 or 4-d IL-7-stimulated thymic cells from 32m + or 32m-  mice were stained with fluorescence-labeled antibodies specific for CD4,  CD8, 
~3TCR,  and analyzed by three-color flow cytometry. Cultures were performed with 15  x  10  e unseparated thymic cells incubated for 4 d  in 0.5 
ml of culture medium containing 100 U/ml hrlL-7. 
*  Results are expressed as viable cell recovery in each subset calculated from 10  s cells at the beginning of culture, in one representative experiment 
out of three. 
and CD4 +  8-  thymocytes before and after 4 d of Ib7 stim- 
ulation of total thymocytes, according to their IL-7R expres- 
sion  (Fig.  1).  Before stimulation,  V[3 expression was  not 
significantly  different  between  CD4-8-oL[3TCR +  and 
CD4+8 -  subpopulations whether they expressed IL-7R or 
not (Fig.  1). After a 4-d stimulation with IL-7, there appeared 
a significant bias in the repertoire towards overusage of the 
V[38.2 gene family among ID7R + thymocytes (Fig.  1). This 
was  the  case  for  both  CD4-8-c*[3TCR +  and  CD4+8 - 
thymocytes, whereas no such bias existed in the V[3 reper- 
toire of cultured  CD4-8 + thymocytes (data not  shown). 
IL,7R Expression Among CIM- 8- ce[3TCR + and CD4+8 - 
Thymocytes  According to VB Usage.  The overexpression of 
the  V[38.2  gene  gamily  by Ib7R +  thymocytes  upon  ex- 
posure to Ib7 is apparently not due to a more important ex- 
pression of IL-7R on V[38.2 + cells  at  the onset of culture 
since we could not detect significant differences in this re- 
spect between V[36 +, V[38.2 +,  and V[314  +,  CD4- 8-,  or 
CD4 +  8-  thymocytes (Table 5).  After 4 d  of IL-7 stimula- 
tion,  the  vast  majority  of CD4-8-  cells  were  IL-7R +, 
whatever the V[3 subset considered (Tables 2 and 5). Among 
CD4 +8-  thymocytes the proportion  of IL-7R + cells  was 
significantly  higher  in  the  V[38.2 +  than  in  the  V[36 +, 
V[314 +,  or the total CD4+8 -  subset (Table 5). 
IL,7 Does  Not Promote  Preferential Expansion  of V[38.2 + 
Thymocytes from [32 Microglobulin-deficient  Mice.  It has re- 
cently been demonstrated that overexpression of the V[38.2 
gene  family  among  CD4-8-o~[3TCR +  thymocytes  is 
largely  due  to  positive  selection  of V[38.2 +  cells  by [32- 
microglobulin-associated class I molecules (11). This finding 
together with  the preferential  growth  of V38.2 + thymo- 
cytes in response to IL7 prompted us to analyze the V[3-TCR 
repertoire of CD4-8-  and CD4+8 -  calls from [32-micro- 
globulin-deficient  mice  ([32m-),  as  compared  to  control 
[32m + littermates, before and after IL-7 stimulation for 4 or 
9 d. II~7 promoted the expansion of CD4-8-c~[3TCR + and 
CD4 +  8-  thymocytes from both [32m + and [32m-  thymo- 
cytes  and  with  similar  efticacy  (Table  6).  In  addition, 
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CD4-8-a3TCR  + and CD4+8 -  thymocytes from 32m + 
and 32m-  mice expressed  similar  levels  of II.-7R in  vivo 
(data not  shown). 
On  analyzing  the repertoire  of freshly isolated CD4-8 
-c~3TCR + thymocytes from [32m-  mice, we found, as de- 
scribed by others (11), no bias towards V38.2 expression (Fig. 
2). Similarly to C3H/HeJ mice, VB8.2 expression by both 
CD4- 8-  and  CD4 +  8- ce3TCR +  IL-7-stimulated  thymo- 
cytes from [32m + mice,  is enhanced.  Yet,  the progressive 
overexpression of V38.2 was more pronounced in CD4 +  8- 
thymocytes.  In  [32m-  mice,  the  repertoire  of CD4-8- 
ol[3TCR + and CD4+8 -  thyrnocytes was unchanged,  even 
after 9 d of IL-7 stimulation (Fig. 2). These results show that 
in our model IL-7 does not induce a specific bias towards V[38.2 
expression in  CD4-8-c~[3TCR + or CD4+8 -  thymocytes 
from [32m-  mice.  They thus provide evidence that  either 
CD4-8-c~[3TCR + or CD4+8 -  thymocytes selected by class 
I  molecules preferentially expand in response to IL-7. 
CD4 +  8-  Thymocytes and Peripheral Lymphocytes from Class 
II-deficient Mice Are Enriched in VB8.2 + Cells.  Mice lacking 
MHC  class  II  molecules  are  not  completely  devoid  of 
CD4+8 -  thymocytes  or  peripheral  T  lymphocytes  (15). 
Therefore,  the rare CD4+8 -  thymocytes could have been 
sdected in the absence of class II molecules, and may repre- 
sent a subpopulation of class I-selected thymocytes. We found 
that not only peripheral CD4+8 -  lymphocytes (15) but also 
CD4+8 -  thymocytes from class II-deficient mice were en- 
riched  in  V[38.2 +  cells  (Fig.  3).  These  in  vivo  findings 
strengthen our in vitro demonstration that a fraction of normal 
CD4 +  8-  thymocytes characterized by overexpression of the 
V[38.2 gene family are sdected by class I molecules. Moreover, 
class I-selected cells could also represent a fraction of periph- 
eral  CD4 + 8-  lymphocytes. 
Co-culture  of B2m +  and  ~2m-  Tlrymocytes  Does  Not 
Change VB8.2 Expression in CD4- 8- orb TCR + or CD4 +  8- 
Thymocytesfrom ~82m- Mice  It has previously been demon- 
strated  that  V[38.2+CD4-8-oe[3TCR +  thymocytes  are 
selected by class I molecules expressed by bone marrow-de- § 
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Figure 2.  V/~-TCR  repertoire of CD4-8-a/~ TCR.  § and CD4*8- 
thymocytes in ~2m+ and t52m- mice before and after 4- and 9-d II.-7 
stimulation. The V/3-TCR repertoire was analyzed by three-color flow 
cytometry in  total  thymocytes from O2-microglobulin-deficient mice 
(/32ra-, hashed)  and control littermates (~2ra*,  solid) before (Day (9) or 
after II~7 stimulation (/~y 4  +  //-,7). This was done in  CD4-8- 
ot/~TCR* (.4) and CD4+8 -  (B) thymocytes. The V/3-TCR repertoire 
is represented  as the percentage  of positive cells. Results are mean percen- 
tages  _+ SD of three separate experiments. 
rived cells  (11).  Moreover,  CD4-8-o~/3TCR +  thymocytes 
from/~2m-  mice can overexpress Vf18.2 in fl2m-  +  B2m + 
mixed chimeras  (11).  For this reason,  we verified whether 
the preferential expansion of V/~8.2*  cells was due to II~7 
rather than an in vitro selection process (13). We thus per- 
formed mixed cultures of fl2m + and B2m-  total thymocytes 
in equal numbers and stimulated them with IL-7 for up to 
9 d  (Fig. 4).  If VBS.2 + thymocytes were selected in vitro, 
we  would  have  expected  to  generate  the  VflS.2  bias  in 
/32m-  thymocytes co-cultured with/~2m § thymocytes. We 
assessed class I expression on thymocytes by examining anti- 
H-2K  b labeling in flow cytometry. After 9-d Ib7 stimula- 
tion,  all  thymocytes  from/~2m +  cultures  were  H-2K  b+, 
whereas  all thymocytes from B2m- cultures  were H-2K  b- 
(data  not  shown).  Thymocytes from  mixed  cultures  were 
~40%  H-2K  b§  (data  not  shown).  When  we  examined 
Vf18.2  expression  among  H-2K  b-  (B2m-  derived)  and 
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Figure 3.  VB8.2  expression in thymic and peripheral CD4+8 -  lym- 
phocytes  from class II-ddicient mice. Three color flow cytometry was used 
to analyze  V/38.2 expression  among CD4*8- lymphocytes  (corresponding 
to the gated R1 population in CD4 versus CD8 dot plots) in the thymus 
(A) and lymph nodes; (B) of class lI-deficient (II ~ right)  and wild-type 
control mice (left). VBS.2 expression is indicated in each log scale histo- 
gram as the percentage of positive cells compared to negative control. 
H-2K  b+  (/~2m + derived), CD4-8-a/~TCK + and CD4+8 - 
thymocytes, we observed no difference between mixed and 
separate cultures (Fig. 4). These experiments establish that 
IL-7 preferentially stimulates VBS.2 + thymocytes previously 
selected by class I  molecules in vivo. 
Discussion 
In the thymus, a small population of CD4+8 + immature 
thymocytes  gives  rise  to  mature  CD4+8 -  and  CD4-8 + 
thymocytes.  During  this  development  process,  the  vast 
majority of the TCR repertoire is positively selected so that 
CD4 + 8-  and CD4- 8 +  thymocytes express TCRs capable 
of interaction with selfMHC class II and I molecules, respec- 
tively (18). However, the striking finding that distinct,  al- 
though rare, populations  of CD4+8 -  thymocytes and pe- 
ripheral T  lymphocytes are present in mice rendered deficient 
in MHC class II expression supports the notion that not all 
CD4 + 8-  thymocytes are positively selected by class II MHC 
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Figure 4.  V3-TCR repertoire 
of  CD4-8-a3  TCR +  and 
CD4+8 -  tbymocytes  in mixed 
cultures  of  32m +  and  32m- 
tbymoeytes  after  a 9<1 Ib7 stimula- 
tion. The V3-TCR repertoire  was 
investigated by three-culor flow 
cytometry in CD4  -  8  -  cx3TCR  + 
(A)  and  CD4+8 -  (B)  thymo- 
cortes from cultures of /32m  +, 
B2m-  and  mixed ~2m +  + 
~2m- thymocytes  after 9-d IL-7 
stimulation. In mixed cultures, 
thymocytes from B2m +  and 
/~2m- were discriminated by the 
use of anti-H-2K  b mAb, as aU 
~/2m +  stimulated  thymocytes 
were H-2Kb+  and all B2m--stimulated thymocytes  were H-2K  b-  in independent  cultures  (data not shown).  Results  are mean percentages  of two 
separate experiments. 
molecules (15,  19). Class I selection of a minute fraction of 
CD4+8 -  thymocytes  could  explain  this  phenomenon. 
However, it is not known if such cells exist in normal mice. 
We observed preferential expansion of normal CD4+8 - 
thymoeytes expressing the VB8.2 gene family in a culture 
system of total thymocytes stimulated by IL-7.  This pref- 
erential expansion generated a bias in the V3-TCR reper- 
toire  of CD4+8 -  thymocytes  towards  overexpression  of 
VB8.2. The VB8.2 bias did not exist among both CD4+8 - 
and  CD4-8-o~BTCR +  IL-7-stimulated  thymocytes from 
32m-deficient mice, despite a similar response to IL-7 stimu- 
lation.  This finding  strongly suggests that  the fraction  of 
CD4 + 8-  thymocytes overexpressing V38.2 that expand in 
our system have previously been selected by class I molecules 
in vivo. Furthermore,  we found that  CD4"8-  thymocytes 
and peripheral T  lymphocytes from class II-deficient mice 
were enriched in VB8.2 + cells.  Taken  together,  these data 
provide  evidence  that,  in  normal  mice,  a  fraction  of 
CD4+8 -  thymocytes may be selected by class I  molecules. 
Moreover, it has been reported that rare subsets of CD4 +  8- 
thymoeytes from normal mice overexpress VB8.2. These cells 
were found in the Ly6C + , NKI.1 +, and HSA-3Gll-defined 
subsets of CD4 +  8- thymocytes, the latter being referred to 
as the Thy0 population (12, 20, 21). Thy0 tbymocytes share 
other  properties  with  CD4- 8- oe3TCR +  thymocytes,  in- 
cluding an enrichment  in CD44 + cells  (22).  We therefore 
conclude that class I-positive selection may contribute to the 
development  of the Thy0 CD4 + 8-  thymocyte subset. 
Several mechanisms could account for the preferential IL- 
7-induced growth of class I-selected CD4- 8 - ol3TCR + and 
CD4 +  8-  thymocytes in our culture conditions. We showed 
that  this phenomenon was not due to an in vitro selection 
process. It is also not explained by overexpression of IL-7R 
on VB8.2+CD4+8 -  thymocytes before culture,  though  it 
cannot  be excluded  that  an  undetectable  fraction  of these 
VB8.2+CD4+8-  thymocytes are enriched in IL-TR + cells 
in vivo. The same conclusion applies to the V38 +  CD4-8- 
population  since  the  vast  majority  of CD4-8-o~BTCR + 
cells were IL-TR before culture, whatever the V3 expressed. 
It  is  thus  possible  that  CD4-8-aBTCR +  thymocytes 
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bearing other V3s are also selected by class I molecules and 
are therefore sensitive to IL-7 stimulation. Indeed, VB8.2 over- 
expression  among  IL-7-stimulated  CD4-8-ol/STCR + 
thymocytes was  only  slightly  enhanced.  In  addition,  our 
method of IL-7R detection does not discriminate between 
IL-7  receptors  of different  affinities.  Finally,  CD4+8 -  or 
CD4-8-  ot3TCR + thymocytes selected by class I molecules 
could have expanded preferentially because they were more 
mature or in an activated state before culture. Indeed, it has 
been  shown  that  both  CD4-8-oeBTCR +  and  Thy0 
CD4 +8- thymocytes are mature cells that respond better to 
various stimuli, including CD3 cross-linking and mitogens, 
than other thymocyte subsets (23, 24). Moreover, it has been 
suggested that the Thy0 subset is composed of activated cells 
(22). 
The particular sensitivity of dass 1-selected CD4+8 -  and 
CD4-8-oIBTCR + thymocytes to IL-7 stimulation leads us 
to speculate on the possible physiological roles of IL-7.  It 
has  been  proposed  that  murine  CD4-8-V38 +  T  cells 
recognize and are selected by a specific set of nonclassical  class 
I molecules, such class Ib or class I-like CD1 molecules (11, 
25). If so, one possible role for these CD4- 8- VB8 + T cells 
would be to recognize stress-  or inflammation-induced  au- 
tologous antigens bound preferentially to class l-like mole- 
cules,  as originally proposed for various subsets of CD4- 8- 
7~TCR +  T  cells  (11, 26-28).  It  is  thus  conceivable that 
a particular  subset  of  T  cells,  including  class  I-selected 
CD4- 8- oL3TCR + and possibly CD4 +  8- T cells, recognize 
a defined set of peptides related to inflammation.  Interest- 
ingly, we have previously found a synergistic effect of IL-1 
on IL-7-dependent thymocyte proliferation  (13). IL-7 is mainly 
expressed by thymic stromal cells (2), but its level is prob- 
ably low in healthyanimals and this could explain why these 
populations are not expanded in normal mice. In contrast, 
the release of IL-7 cofactors like IL-1 during inflammation 
may promote their preferential expansion in other organs, 
together  with  the release of IL-7 by particular  cells,  e.g., 
keratinoeytes (29).  Another function of CD4-8-o~3TCR + 
and Thy0 CD4 +  8- thymocytes is related to their ability to 
produce IL-4 upon stimulation (12, 23, 24). IL-4 is a major regulatory molecule of peripheral immune responses, mod- 
ulating Th2 versus Thl responses (30).  Interestingly, IL-4 
itself seems to be necessary to induce IL-4 production by con- 
ventional peripheral CD4 +  8-  T  cells (31).  IL-4-producing 
thymocytes could therefore be a source of IL-4 which may 
influence the peripheral Thl/Th2 balance. If so, the role of 
IL-7 in the proliferation of thymic IL-4 producers, which re- 
mains to be fully demonstrated, would be of major relevance. 
We thank E. Schneider, B. Rocha, S. Ezine, and A.  Zlotnik  for helpful discussions and advice and F. 
Vasseur for expert technical assistance. We are particularly indebted to Dr. Gillis (Immunex Research and 
Development Corporation,  Seattle, WA) and to Sterling Winthrop Inc. (CoUegeville,  PA) for providing 
us with IL-7. 
This work was supported by institute  funds from the INSERM and the CNKS, and by a grant  to A. 
Vicari from the Association pour la Recherche sur le Cancer, and a grant to M. do C. Leite de Moraes 
and to J. M.  Gombert from the Fondation pour la Recherche M6dicale. 
Address correspondence to Dr. Alain Vicari, DNAX Research Institute, 901 California Avenue, Palo Alto, 
CA 94304-1104. 
Received for publication 25January  1994 and in revised form  1 April  1994. 
References 
1.  Boyd, R.L., and P. Hugo. 1991. Toward an integrated view 
of thymopoiesis. Immunol. Today 12:71. 
2.  Sakata, T., S. Iwagami, Y. Tsuruta, H. Teraoka, Y. Tatsumi, 
Y. Kita, S.I. Nishikawa, Y. Takai, and H. Fujiwara. 1990. Con- 
stitutive expression of interleukin-7 mRNA and production 
of IL-7 by a cloned murine thymic stromal cell line. J. Leuko- 
cyte Biol. 48:205. 
3.  Rich, B.E., J. Campos-Torres, R.I. Tepper, R.W. Moreadtih, 
and P. Leder. 1993. Cutaneous lymphoproliferation and lym- 
phomas in Interleukin 7 transgenic mice.J. Exla Med. 177:305. 
4.  Samaridis, J., G. Casorati, A. Traunecker, J.C. Guttierez,  U. 
Mtiller, and Ik. Palacios. 1991. Development of lymphocytes 
in interleukin  7-transgenic mice. Eur. J. Immunol. 21:453. 
5.  Godfrey, D.I., J. Kennedy, T. Suda, and A. Zlotnik.  1993. A 
developmental  pathway involving four phenotypically and func- 
tionally distinct subsets of CD3-CD4-CD8-  triple-negative 
adult mouse thymocytes defined by CD44 and CD25 expres- 
sion. J. Immunol. 150:4244. 
6.  Suda, T.,  and  Z.  Zlotnik.  1991. IL-7 maintains  the T  cell 
precursor potential of CD3-CD4-CDS-  thymocytes. J. Ira- 
munol. 146:3068. 
7.  Murray, Ik., T. Suda, N. Wrighton, F. Lee, and A. Zlotnik. 
1989. I1.,7 is a growth and maintenance factor for mature and 
immature thymocyte subsets. Int. Iramunol. 1:526. 
8.  Suda, T., K. Murray, C. Guidos, and A. Zlomik. 1990. Growth- 
promoting activity of Iblc~, IL-6, and tumor necrosis factor-or 
in combination with IL-2, IL-4  or IL-7  on murine thymocytes. 
Differential effects  on CD4/CD8 subsets and on CD3 +/CD3- 
double-negative thymocytes. J. Immunol. 144:3039. 
9.  Folwkes, B.J., A.M. Kruisbeek, H. Hon-That, A. Weston, J.E. 
Coligan,  K.H. Schwartz, and D.M.  Pardoll. 1987. A novel 
population  of T-cell receptor orB-bearing thymocytes which 
predominantly  express a  single VB  family. Nature (Lond.). 
329:251. 
10.  Takahama, Y., A. Kosugi, and A. Singer. 1991. Phenotype, 
ontogeny and repertoire of CD4-CD8- T cell receptor cr  + 
thymocytes:  variable  influence  of self-antigens  on T cell receptor 
V/3 usage. J. Immunol. 146:1134. 
11.  Bix, M., M. Coles, and D. Raulet.  1993. Positive selection 
of V~8+CD4-8 -  thymocytes by class I molecules expressed 
by hematopoietic cells. J. Exl~ Med. 178:901. 
12.  Hayakawa,  K., B.T. Lin, and R.R. Hardy. 1992. Murine thymic 
CD4 + T  cell subsets: a subset (Thy0) that secretes diverse 
cytokines and overexpresses  the VB8 T cell receptor gene family. 
J. Ext~ Med. 176:269. 
13.  Herbelin, A., F. Machavoine, E. Schneider, M. Papiernik, and 
M.  Dy.  1992. IL-7 is requisite for IL-1 induced  thymocyte 
proliferation. Involvement of IL-7 in the synergistic effects of 
granulocyte macrophage colony-stimulating factor of tumor 
necrosis factor. J. Immunol. 148:99. 
13a.Herbelin,  A.,  F.  Machavoine, A.  Vicari, E.  Schneider, M. 
Papiernik, H. Ziltener, C. Penit, and M. Dy. 1994. Endoge- 
nous granulocyte macrophage-colony stimulating factor (GM- 
CSF) is involved in Ibl and Ib7-induced murine thymocyte 
proliferation. J. Immunol. In press. 
14.  Koller, B.H., P. Marrack, J.W. Kappler, and O. Smithies. 1990. 
Normal development of mice deficient in/~2-Microglobulin, 
MHC class I proteins, and CD8 + T cells. Science (Wash. DC). 
248:1227. 
15.  Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, 
C. Benoist, and D. Mathis. 1991. Mice lacking MHC class 
II molecules. Cell. 66:1051. 
16.  Armitage, K.J., S.F. Ziegler, D.J. Friend, L.S. Park, and W.C. 
Fanslow. 1992. Identification of a novel low-af~nity receptor 
for human  interleukin-7. Blood. 79:1738. 
17.  Penit, C., and F. Vasseur. 1993. Phenotype analysis of cycling 
and postcycling thymocytes: evaluation of detection methods 
for BrdUrd and surface proteins. Cytometry. 14:757. 
18.  Folwkes, B.J., and D.M. Pardoll. 1989. Molecular and cellular 
events in T cell development. Adv. Immunol.. 44:207. 
19.  Viville, S., J. Nee0es, V. Lotteau, A. Dierich, M. Lemeur, H. 
Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking in the 
660  Interleukin  7 Stimulates Class I.selected CD4-8-  and CD4§  -  Thymocytes MHC class II-associated  invariant chain.  Cell. 73:635. 
20.  Arase, H., N. Arase, K. Nagakawa, R.A. Good and K. Onoe. 
1993.  NKI.I+CD4+CD8-  thymocytes with  specific  lym- 
phokine secretion. Fur. J. Immunol.  23:307. 
21.  Takahama,  Y., S.O. Sharow,  and Singer.  1991. Expression of 
an unusual T  cell receptor (TCR)-V/3 repertoire by Ly-6C § 
subpopulations  of CD4 + and/or CD8 + thymocytes. J.  Im- 
munol.  147:2883. 
22.  Bendelac,  A., P. Matzinger, R.A. Seder, W.E. Paul, and R. 
Schwartz. 1992. Activation events during thymic selection.J. 
Ext~ Med. 175:731. 
23.  Zlotnik,  A.,  D.I.  Godfrey, M.  Fischer,  and T.  Suda.  1992. 
Cytokine production by mature and immature CD4-8-  T 
cells, j. Immunol.  149:1211. 
24.  Bendelac,  A.,  and R. Schwartz.  1991. CD4 + and CD8 + T 
cells acquire specific lymphokine secretion potential during 
thymic maturation. Nature (Lond.). 353:68. 
25.  Stroynowoski,  I.  1990.  Molecules  related  to  class-I  major 
histocompatibility complex antigens.  Annu.  Rev. Immunol. 
8:501. 
26.  O'Brien, R., M.P. Happ, A. Dallas, E. Palmer, R. Kubo, and 
W.K. Born. 1989. Stimulation of a major subset  of lympho- 
cytes expressing T cell receptor 3"6 by an antigen derived from 
myobacterium tuberculosis.  Cell. 57:667. 
27. Janeway, C.A., B. Jones, and A. Hayday. 1988. Specificity and 
function ofT cells bearing 3"6 receptors. Imraunol. Toda  7. 9:73. 
28.  Asarnow,  D.M., W.A. Kuziel, M. Bonyhadi, R..E. Tigelaar, 
P. W. Tucker, and J.P. Allison. 1988. Limited diversity of 3'6 
antigen receptors genes of Thy-1 + dendritic epidermal cells. 
Cell. 55:837. 
29.  Matsue,  H.,  P.R.  Bergstresser,  and  A.  Takashima.  1993. 
Keratinocyte-derived I1.,7 serves as a growth factor for den- 
dritic epidermal T  cells in mice. J.  Immunol.  151:6012. 
30.  Trinchieri, G. 1993. Interleukin-12 and its role in the genera- 
tion of TH1 cells. Immunol.  Today 14:335. 
31.  Le Gros, G., S.Z. Ben-Sasson,  Ik. Zeder, F.D. Finkelman, and 
W.E. Paul. 1990. Generation ofinterleukin 4 (IL-4)-producing 
cells in vivo and in vitro: Ib2 and Ib4 are required for in vitro 
generation of Ib4-producing cells, j. Extx  Med. 172:921. 
661  Vicari et al. 